n.a. (WX)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Latest News

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate

WuXi PharmaTech (WX) Showing Signs Of Being Strong And Under The Radar

WuXi PharmaTech (WX) Showing Signs Of Being Strong And Under The Radar

Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate

Strong And Under The Radar Today: WuXi PharmaTech (WX)

Strong And Under The Radar Today: WuXi PharmaTech (WX)

Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate

Strong And Under The Radar: WuXi PharmaTech (WX)

Strong And Under The Radar: WuXi PharmaTech (WX)

Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate

Claritas Launches The First Clinical Exome Test That Gives Healthcare Providers Multiple Options To Obtain Answers For Patients Quickly And Cost-Effectively

Claritas Launches The First Clinical Exome Test That Gives Healthcare Providers Multiple Options To Obtain Answers For Patients Quickly And Cost-Effectively

Claritas Clinical Exome delivers confirmed whole-exome test results within 4 weeks compared to industry standard of 12 weeks or more Claritas Exome-Based Tests Simplify Use of Exomes in the Clinic to Guide Precision Care for Kids

WuXi PharmaTech (WX) Stock Gains on Buyout Offer

WuXi PharmaTech (WX) Stock Gains on Buyout Offer

WuXi PharmaTech (WX) shares are higher after the company received a $3.3 billion buyout proposal from New WuXi Life Science, consortium.

WuXi PharmaTech And TruTag Technologies Complete Successful Testing Of Edible On-Dose Authentication Solution For Pharmaceuticals

WuXi PharmaTech And TruTag Technologies Complete Successful Testing Of Edible On-Dose Authentication Solution For Pharmaceuticals

Covert, edible technology can be used to manage the pharmaceutical supply chain, prevent counterfeiting or diversion, and provide product informatics

WuXi PharmaTech (WX) Stock: Weak On High Volume Today

WuXi PharmaTech (WX) Stock: Weak On High Volume Today

Trade-Ideas LLC identified WuXi PharmaTech (WX) as a weak on high relative volume candidate

'Jurassic World' Shows Movie Making Can Be a Very Healthy Business

'Jurassic World' Shows Movie Making Can Be a Very Healthy Business

With the unexpectedly massive opening weekend success of 'Jurassic World,' box office revenues are becoming even more central to Comcast’s profits.